Uncover key drivers, emerging technologies, and competitive movements shaping the autoimmune disease diagnosis market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Autoimmune Disease Diagnosis Market’s size between 2026 and 2030?
The autoimmune disease diagnosis market has experienced robust expansion over recent years. Projections indicate its size will expand from $6.2 billion in 2025 to $6.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.8%. This historical increase is primarily due to several factors, including the rising incidence of autoimmune conditions, enhanced access to immunoassay technologies, the broadening of clinical laboratory networks, heightened physician understanding of autoimmune ailments, and a greater uptake of standard screening procedures.
The autoimmune disease diagnosis market size is projected to experience robust expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $9.38 billion, exhibiting a compound annual growth rate (CAGR) of 8.6%. Factors contributing to this growth over the projected period include a heightened need for timely and precise diagnoses, the expanding application of AI-assisted diagnostic analytics, the development of customized diagnostic methods, increased funding for autoimmune research, and the greater incorporation of point-of-care testing. Key trends anticipated during the forecast period encompass a wider embrace of sophisticated immunological testing, an increase in the utilization of autoantibody panels, the growing integration of multiplex diagnostic platforms, the expansion of automated laboratory processes, and an intensified emphasis on detecting diseases at an early stage.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp
Which Drivers Are Shaping Strategic Decisions In The Autoimmune Disease Diagnosis Market?
The high prevalence of autoimmune diseases has contributed to the expansion of the autoimmune disease diagnosis market. These conditions involve the body’s immune system erroneously attacking its own healthy cells, tissues, or organs. The rise in autoimmune diseases is attributed to increased exposure to environmental triggers such as pollution and infections, as well as lifestyle changes that can disrupt immune regulation. Autoimmune disease diagnosis is crucial for accurately identifying specific immune disorders, allowing for the initiation of appropriate treatment and better management of disease progression. For instance, in March 2023, the Society for Women’s Health Research, a U.S-based non-profit organisation, reported that autoimmune diseases are estimated to affect 23.5 million to 50 million individuals. Furthermore, the global rates of autoimmune diseases are increasing by between 3-9 percent annually. Consequently, the rising incidence of autoimmune diseases worldwide is fueling the growth of the autoimmune disease diagnosis market. Anticipated increases in healthcare expenditures are expected to propel the growth of the autoimmune disease diagnosis market in the coming years. Healthcare expenditure is defined as the total amount of funds utilized for healthcare products and services, serving as a key indicator of a population’s health and the success of its healthcare system. Greater healthcare spending enables more prompt healthcare services, leading to improved identification, treatment, and outcomes for individuals with autoimmune illnesses. For instance, in May 2024, the Office for National Statistics, a UK-based government department, indicated that total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, representing a notable acceleration compared to the 0.9% increase observed in 2022. Therefore, growing healthcare expenditures are driving the autoimmune disease diagnosis market.
What Segment Classifications Make Up The Autoimmune Disease Diagnosis Market?
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
3) By End User: Clinical Laboratories, Hospitals, Other End Users
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes
What Trends Are Expected To Impact The Competitive Landscape Of The Autoimmune Disease Diagnosis Market?
Major companies in the autoimmune disease diagnosis market are prioritizing the development of technological advancements, such as multiplex autoantibody assay platforms, to achieve comprehensive, early, and precise detection of autoimmune disorders, ultimately enhancing diagnostic accuracy and patient management. A multiplex autoantibody assay platform enables the simultaneous identification of multiple disease-specific autoantibodies within a single patient sample, which improves sensitivity and specificity compared to traditional single-analyte ELISA or immunofluorescence tests, while also reducing the required sample volume and overall turnaround time. For example, in January 2025, Exagen Inc., a U.S.-based diagnostics company, launched its AVISE CTD platform featuring new assays for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) biomarkers. This platform detects novel biomarkers like TIgG, TIgM, and TC4d, allowing clinicians to more accurately distinguish between overlapping autoimmune conditions and streamline patient diagnosis, all while seamlessly integrating with existing testing workflows.
Which Leading Companies Dominate The Autoimmune Disease Diagnosis Market Share?
Major companies operating in the autoimmune disease diagnosis market are Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc, bioMérieux SA, SQI Diagnostics, Philips Healthcare India, Agappe Diagnostics Ltd, Lepu Medical Technology Company (Beijing) Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Becton Dickinson and Company, Ortho Clinical Diagnostics
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
How Does The Autoimmune Disease Diagnosis Market Perform Across Major Global Regions?
North America was the largest region in the autoimmune disease diagnosis market in 2025. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Autoimmune Disease Diagnosis Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3231&type=smp
Browse Through More Reports Similar to the Global Autoimmune Disease Diagnosis Market 2026, By The Business Research Company
Veterinary Autoimmune Disease Therapeutics Market Report 2026
Autoimmune Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Immunodiagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
